$1.23 1.7%
NUWE Stock Price vs. AI Score
Data gathered: February 5

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Nuwellis

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.


Nuwellis
Price $1.23
Target Price Sign up
Volume 188,190
Market Cap $5.3M
Year Range $0.98 - $9.66
Dividend Yield 0%
Analyst Rating 0% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '242.4M3.4M1.7M2.4M2.4M1.740
Q2 '242.2M4M1.5M-7.7M-2M-18.850
Q1 '241.9M5.3M1.2M-4.3M-4.7M-0.600
Q4 '236.5M5.1M1.4M-5.5M-3.5M-1.560
Q3 '232.4M4.5M1.4M-3.4M-3.1M-1.810

Insider Transactions View All

Jaramillo Nestor Jr. filed to buy 4,098 shares at $4.8.
March 16 '23

What is the Market Cap of Nuwellis?

The Market Cap of Nuwellis is $5.3M.

What is the current stock price of Nuwellis?

Currently, the price of one share of Nuwellis stock is $1.23.

How can I analyze the NUWE stock price chart for investment decisions?

The NUWE stock price chart above provides a comprehensive visual representation of Nuwellis' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Nuwellis shares. Our platform offers an up-to-date NUWE stock price chart, along with technical data analysis and alternative data insights.

Does NUWE offer dividends to its shareholders?

As of our latest update, Nuwellis (NUWE) does not offer dividends to its shareholders. Investors interested in Nuwellis should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Nuwellis?

Some of the similar stocks of Nuwellis are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.